Bio21 - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 10 of 556
  • Item
    No Preview Available
    Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure
    Faysal, KMR ; Walsh, JC ; Renner, N ; Marquez, CL ; Shah, VB ; Tuckwell, AJ ; Christie, MP ; Parker, MW ; Turville, SG ; Towers, GJ ; James, LC ; Jacques, DA ; Bocking, T (eLIFE SCIENCES PUBL LTD, 2024-02-13)
    The HIV-1 capsid has emerged as a tractable target for antiretroviral therapy. Lenacapavir, developed by Gilead Sciences, is the first capsid-targeting drug approved for medical use. Here, we investigate the effect of lenacapavir on HIV capsid stability and uncoating. We employ a single particle approach that simultaneously measures capsid content release and lattice persistence. We demonstrate that lenacapavir's potent antiviral activity is predominantly due to lethal hyperstabilisation of the capsid lattice and resultant loss of compartmentalisation. This study highlights that disrupting capsid metastability is a powerful strategy for the development of novel antivirals.
  • Item
    No Preview Available
    Free drug percentage of moxidectin declines with increasing concentrations in the serum of marsupials
    Stott, EK ; Nie, S ; Williamson, NA ; Skerratt, LF (ELSEVIER, 2024-04)
    Moxidectin (MOX) is a macrocyclic lactone used to eliminate endo and ectoparasites in many mammalian species. It is notably the active ingredient of the anti-parasitic drug Cydectin®, manufactured by Virbac, and is frequently used to treat sarcoptic mange in Australian wildlife. Protein binding plays a significant role in the efficacy of a drug, as the unbound/free drug in plasma ultimately reflects the pharmacologically relevant concentration. This study aimed to investigate the free drug percentage of Moxidectin after in vitro spiking into the sera of four sarcoptic mange-susceptible Australian wildlife species; the koala (Phascolarctos cinereus), the bare-nosed wombat (Vombatus ursinus), the eastern grey kangaroo (Macropus giganteus), and the mountain brushtail possum (Trichosurus cunninghami). Three concentration points of MOX were tested for each individual: 20 pg/μL, 100 pg/μL and 500 pg/μL. Serum from five individuals of each species underwent an equilibrium dialysis followed by liquid chromatography tandem mass spectrometry (LC-MS/MS). The results showed an atypical concentration dependent binding across all species, where free drug percentage decreased as MOX concentration increased. In addition, wombats showed significantly lower free drug levels. These findings call for further research into the mechanisms of moxidectin protein binding to help understand MOX pharmacokinetics in marsupials.
  • Item
    No Preview Available
    Structure-activity relationship and target investigation of 2-aryl quinolines with nematocidal activity
    Shanley, HT ; Taki, AC ; Nguyen, N ; Wang, T ; Byrne, JJ ; Ang, C-S ; Leeming, MG ; Nie, S ; Williamson, N ; Zheng, Y ; Young, ND ; Korhonen, PK ; Hofmann, A ; Chang, BCH ; Wells, TNC ; Haberli, C ; Keiser, J ; Jabbar, A ; Sleebs, BE ; Gasser, RB (ELSEVIER SCI LTD, 2024-04)
    Within the context of our anthelmintic discovery program, we recently identified and evaluated a quinoline derivative, called ABX464 or obefazimod, as a nematocidal candidate; synthesised a series of analogues which were assessed for activity against the free-living nematode Caenorhabditis elegans; and predicted compound-target relationships by thermal proteome profiling (TPP) and in silico docking. Here, we logically extended this work and critically evaluated the anthelmintic activity of ABX464 analogues on Haemonchus contortus (barber's pole worm) - a highly pathogenic nematode of ruminant livestock. First, we tested a series of 44 analogues on H. contortus (larvae and adults) to investigate the nematocidal pharmacophore of ABX464, and identified one compound with greater potency than the parent compound and showed moderate activity against a select number of other parasitic nematodes (including Ancylostoma, Heligmosomoides and Strongyloides species). Using TPP and in silico modelling studies, we predicted protein HCON_00074590 (a predicted aldo-keto reductase) as a target candidate for ABX464 in H. contortus. Future work aims to optimise this compound as a nematocidal candidate and investigate its pharmacokinetic properties. Overall, this study presents a first step toward the development of a new nematocide.
  • Item
    No Preview Available
    Structure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans
    Shanley, HT ; Taki, AC ; Nguyen, N ; Wang, T ; Byrne, JJ ; Ang, C-S ; Leeming, MG ; Nie, S ; Williamson, N ; Zheng, Y ; Young, ND ; Korhonen, PK ; Hofmann, A ; Wells, TNC ; Jabbar, A ; Sleebs, BE ; Gasser, RB (PERGAMON-ELSEVIER SCIENCE LTD, 2024-01-15)
    Global challenges with treatment failures and/or widespread resistance in parasitic worms against commercially available anthelmintics lend impetus to the development of new anthelmintics with novel mechanism(s) of action. The free-living nematode Caenorhabditis elegans is an important model organism used for drug discovery, including the screening and structure-activity investigation of new compounds, and target deconvolution. Previously, we conducted a whole-organism phenotypic screen of the 'Pandemic Response Box' (from Medicines for Malaria Venture, MMV) and identified a hit compound, called ABX464, with activity against C. elegans and a related, parasitic nematode, Haemonchus contortus. Here, we tested a series of 44 synthesized analogues to explore the pharmacophore of activity on C. elegans and revealed five compounds whose potency was similar or greater than that of ABX464, but which were not toxic to human hepatoma (HepG2) cells. Subsequently, we employed thermal proteome profiling (TPP), protein structure prediction and an in silico-docking algorithm to predict ABX464-target candidates. Taken together, the findings from this study contribute significantly to the early-stage drug discovery of a new nematocide based on ABX464. Future work is aimed at validating the ABX464-protein interactions identified here, and at assessing ABX464 and associated analogues against a panel of parasitic nematodes, towards developing a new anthelmintic with a mechanism of action that is distinct from any of the compounds currently-available commercially.
  • Item
    Thumbnail Image
    NMR techniques for investigating antimicrobial peptides in model membranes and bacterial cells
    Sani, M-A ; Rajput, S ; Keizer, DW ; Separovic, F (Elsevier BV, 2024-04)
    AMPs are short, mainly cationic membrane-active peptides found in all living organism. They perform diverse roles including signaling and acting as a line of defense against bacterial infections. AMPs have been extensively investigated as templates to facilitate the development of novel antimicrobial therapeutics. Understanding the interplay between these membrane-active peptides and the lipid membranes is considered to be a significant step in elucidating the specific mechanism of action of AMPs against prokaryotic and eukaryotic cells to aid the development of new therapeutics. In this review, we have provided a brief overview of various NMR techniques commonly used for studying AMP structure and AMP-membrane interactions in model membranes and whole cells.
  • Item
    No Preview Available
    Polymeric Nanoneedle Arrays Mediate Stiffness‐Independent Intracellular Delivery (Adv. Funct. Mater. 3/2022)
    Yoh, HZ ; Chen, Y ; Aslanoglou, S ; Wong, S ; Trifunovic, Z ; Crawford, S ; Lestrell, E ; Priest, C ; Alba, M ; Thissen, H ; Voelcker, NH ; Elnathan, R (Wiley, 2022-01)
    In article number 2104828, Yaping Chen, Nicolas H. Voelcker, Roey Elnathan, and co-workers demonstrate the fabrication of relatively low-cost and high throughput polymeric nanoneedles from cell culture polystyrene. The nanoneedles with precise geometry are imprinted directly on polystyrene from the cell culture petri dish via nanoimprint lithography. The nanoneedles arrays can precisely manipulate cellular processes and mediate intracellular delivery in mammalian cells. This presents opportunities for novel integration of nanostructures into traditional polymeric cell cultureware.
  • Item
    Thumbnail Image
    Development of Matrix-Embedded Bovine Tracheal Organoids to Study the Innate Immune Response against Bovine Respiratory Disease
    Quah, PS ; Tran, BM ; Corbin, VDA ; Chang, JJ-Y ; Wong, CY ; Diaz-Méndez, A ; Hartley, CA ; Zeng, W ; Hanssen, E ; Trifunovic, Z ; Reading, PC ; Jackson, DC ; Vincan, E ; Coin, LJM ; Deliyannis, G (MDPI, 2023)
    Bovine respiratory disease (BRD) is the leading cause of morbidity and mortality in feedlot cattle. Bovine herpesvirus-1 (BHV-1) is one of the main culprits of BRD; however, research on BHV-1 is hampered by the lack of suitable models for infection and drug testing. In this study, we established a novel bovine tracheal organoid culture grown in a basement membrane extract type 2 (BME2) matrix and compared it with the air–liquid interface (ALI) culture system. After differentiation, the matrix-embedded organoids developed beating cilia and demonstrated a transcriptomic profile similar to the ALI culture system. The matrix-embedded organoids were also highly susceptible to BHV-1 infection and immune stimulation by Pam2Cys, an immunomodulator, which resulted in robust cytokine production and tracheal antimicrobial peptide mRNA upregulation. However, treatment of bovine tracheal organoid cultures with Pam2Cys was not sufficient to inhibit viral infection or replication, suggesting a role of the non-epithelial cellular microenvironment in vivo.
  • Item
    No Preview Available
    The Proteome and Lipidome of Extracellular Vesicles from Haemonchus contortus to Underpin Explorations of Host-Parasite Cross-Talk
    Wang, T ; Koukoulis, TF ; Vella, LJ ; Su, H ; Purnianto, A ; Nie, S ; Ang, C-S ; Ma, G ; Korhonen, PK ; Taki, AC ; Williamson, NA ; Reid, GE ; Gasser, RB (MDPI, 2023-07)
    Many parasitic worms have a major adverse impact on human and animal populations worldwide due to the chronicity of their infections. There is a growing body of evidence indicating that extracellular vesicles (EVs) are intimately involved in modulating (suppressing) inflammatory/immune host responses and parasitism. As one of the most pathogenic nematodes of livestock animals, Haemonchus contortus is an ideal model system for EV exploration. Here, employing a multi-step enrichment process (in vitro culture, followed by ultracentrifugation, size exclusion and filtration), we enriched EVs from H. contortus and undertook the first comprehensive (qualitative and quantitative) multi-omic investigation of EV proteins and lipids using advanced liquid chromatography-mass spectrometry and informatics methods. We identified and quantified 561 proteins and 446 lipids in EVs and compared these molecules with those of adult worms. We identified unique molecules in EVs, such as proteins linked to lipid transportation and lipid species (i.e., sphingolipids) associated with signalling, indicating the involvement of these molecules in parasite-host cross-talk. This work provides a solid starting point to explore the functional roles of EV-specific proteins and lipids in modulating parasite-host cross-talk, and the prospect of finding ways of disrupting or interrupting this relationship to suppress or eliminate parasite infection.
  • Item
    No Preview Available
    Selenium Nanoparticles as Potential Drug-Delivery Systems for the Treatment of Parkinson's Disease
    Kalcec, N ; Peranic, N ; Mamic, I ; Beus, M ; Hall, CR ; Smith, TA ; Sani, MA ; Turcic, P ; Separovic, F ; Vrcek, IV (AMER CHEMICAL SOC, 2023-09-20)
  • Item
    No Preview Available
    Encounter Complexes Between the N-terminal of Neurotensin with the Extracellular Loop 2 of the Neurotensin Receptor 1 Steer Neurotensin to the Orthosteric Binding Pocket
    Asadollahi, K ; Rajput, S ; Jameson, GNL ; Scott, DJ ; Gooley, PR (ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2023-10-15)
    Neurotensin (NT) is a linear disordered peptide that activates two different class A GPCRs, neurotensin receptor 1 (NTS1) and NTS2. Resolved structures of the complex of the C-terminal fragment of NT, NT8-13, with NTS1 shows the peptide takes a well-defined structure in the bound state. However, the mechanisms underlying NT recognition of NTS1, and the conformational transition of NT upon binding NTS1 is an open question that if answered may aid discovery of highly selective drugs and reveal potential secondary binding sites on the surface of the receptor. Herein we investigated the interactions guiding NT to the orthosteric binding pocket of NTS1 by combining NMR experiments with kinetic analysis of the binding pathway using stopped-flow fluorescence and mutagenesis on both NT and NTS1. We show the presence of transient structures in the middle part of NT that kinetically regulate the binding of NT to NTS1. Moreover, our results indicate that the binding pathway of NT onto NTS1 is mediated via electrostatic interactions between the N-terminal region of NT with the extracellular loop 2 of NTS1. These interactions induce backbone conformational changes in neurotensin similar to the bound-state neurotensin, suggesting that the N-terminal region of NT and these interactions should be considered for development of selective drugs against NTS1.